AdvaMed Opposes Renewal of Medical Device Repair Exemption
AdvaMed opposes renewal of the medical device repair exemption, citing new legal and manufacturer evidence that the prior rulemaking record no longer supports renewal.
Legal
Learn more about our Legal work.
When is software not just software?
When is software not just software? That’s the question at the center of comments AdvaMed recently filed with the U.S. Copyright Office. At first glance, this may sound like a…
AdvaMed Comment Letter to OIG’s RFI on Clinical Trial Remuneration and Fraud & Abuse Laws
AdvaMed urges OIG to modernize Anti-Kickback Statute and Beneficiary Inducements CMP rules with a clinical trial-specific safe harbor to provide greater clarity for reasonable participant remuneration and support arrangements.
Stop Counterfeit & Grey Market Medical Devices at the Border
Gain a focused overview of how to record intellectual property with CBP to stop counterfeit & grey market medical Devices at the border
Medtech Compliance Is More Complex so We Built a Program to Match
The AdvaMed Medtech Compliance Workshop is a forum designed specifically for medtech compliance leaders and legal and other professionals with health care compliance responsibilities.
AdvaMed® Medtech Compliance Workshop
Join AdvaMed® and Porzio for this comprehensive compliance workshop to better understand the current medtech compliance framework.
AdvaMed® Urges Georgia Court of Appeals to Enforce Sound Science in Ethylene Oxide Litigation
WASHINGTON—AdvaMed, the MedTech Association®, the world’s largest medtech trade association, representing over 650 medical technology innovators, has filed an amicus curiae brief in the Walker v. Becton, Dickinson and Company…
AdvaMed® Comment Letter to OIG’s Annual Solicitation for Safe Harbors and Special Fraud Alerts
AdvaMed® comment letter to the OIG’s recommends updates to safe harbors, value-based arrangements, & oversight to support value-driven healthcare.
RFI: National Strategic Plan for Advanced Manufacturing Letter
This comment letter fromAdvaMed® responds to the OSTP’s Request for Information on National Strategic Plan for Advanced Manufacturing (“OSTP RFI”).
Supreme Court Term in Review: Implications for the Medical Technology Industry
Supreme Court Term in Review: Implications for the Medical Technology Industry